Skip to content

Effect of Pyramidal Aerobic Training on Ventilatory Function in Cigarette Smokers

Effect of Pyramidal Aerobic Training on Ventilatory Function in Cigarette Smokers

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07765485
Enrollment
40
Registered
2026-08-14
Start date
2025-09-06
Completion date
2026-04-15
Last updated
2026-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette Smoking, Impaired Ventilatory Function, Respiratory Function in Adult Smokers

Brief summary

Statement of the problem: Does the pyramidal aerobic training affect ventilatory function parameters in smokers? Null hypothesis: Pyramidal aerobic training has no significant effect on ventilatory function parameters (such as Forced Vital Capacity \[FVC\], Forced Expiratory Volume in one second \[FEV₁\], and Peak Expiratory Flow Rate \[PEFR\]) in adult smokers.

Detailed description

This randomized controlled trial evaluates the effect of an eight-week pyramidal aerobic training program on ventilatory function in cigarette smokers. Forty male cigarette smokers aged 18 to 28 years will be randomly allocated to either a pyramidal aerobic training group or a control group. The intervention group will perform treadmill-based pyramidal aerobic training three times per week for eight consecutive weeks. Each session will include a warm-up, pyramidal aerobic training with ascending and descending intensity levels, and a cool-down. Training intensity will range from 20% to 80% of the participant's target heart rate calculated using the Karvonen formula. Ventilatory function will be assessed by spirometry, while functional capacity, health-related quality of life, and smoking abstinence self-efficacy will also be assessed at baseline and after the intervention.

Interventions

BEHAVIORALPyramidal Aerobic Training

Pyramidal aerobic training performed on a motorized treadmill three times per week for eight consecutive weeks. Each session consists of 5 minutes of warm-up, 20 minutes of pyramidal aerobic training with 5 ascending and 5 descending intensity levels, each lasting 2 minutes, followed by 5 minutes of cool-down. Training intensity ranges from 20% to 80% of the participant's target heart rate calculated using the Karvonen formula, with heart rate monitored using a pulse oximeter.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Participants will be randomly assigned into two parallel groups: a pyramidal aerobic training group and a control group.

Eligibility

Sex/Gender
MALE
Age
18 Years to 28 Years
Healthy volunteers
No

Inclusion criteria

* Cigarette smoker males aged from 18 to 28 years. * Smoking index = 50. * Sedentary lifestyle. * BMI between 18.5 and 29.9 kg/m². * Cigarette smokers demonstrate mild to moderate impairment in ventilatory function confirmed by baseline spirometry. * SASEQ (Smoking Abstinence Self-Efficacy Questionnaire) moderate self-efficacy, score from 9 to 16. * Cigarette smokers are able and willing to participate in aerobic training sessions

Exclusion criteria

* Patients diagnosed with chronic respiratory diseases such as asthma. * Patients with cardiovascular diseases or other systemic illnesses that contraindicate exercise. * Patients who experienced recent respiratory infections within the last 4 weeks. * Patients currently engaged in regular structured aerobic or respiratory training programs.

Design outcomes

Primary

MeasureTime frame
FEV1/FVC RatioBaseline and after 8 weeks of intervention
Forced Expiratory Volume in 1 Second (FEV1)Baseline and after 8 weeks of intervention
Forced Vital Capacity (FVC)Baseline and after 8 weeks of intervention
Peak Expiratory Flow Rate (PEFR)Baseline and after 8 weeks of intervention

Secondary

MeasureTime frameDescription
Health-Related Quality of Life (SF-12)Baseline and after 8 weeks of intervention
Functional Capacity (VO2max)Baseline and after 8 weeks of intervention
Smoking Abstinence Self-Efficacy Questionnaire (SASEQ) ScoreBaseline and after 8 weeks of interventionSmoking abstinence self-efficacy will be assessed using the Smoking Abstinence Self-Efficacy Questionnaire (SASEQ). The questionnaire score ranges from 9 to 16, with higher scores indicating greater smoking abstinence self-efficacy.

Countries

Egypt

Contacts

PRINCIPAL_INVESTIGATORTarek Taha Fathy

Cairo University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 15, 2026